18.02.2015 Views

Financial Statements of - Shoppers Drug Mart

Financial Statements of - Shoppers Drug Mart

Financial Statements of - Shoppers Drug Mart

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SHOPPERS DRUG MART CORPORATION<br />

Notes to the Consolidated <strong>Financial</strong> <strong>Statements</strong><br />

(unaudited)<br />

(in thousands <strong>of</strong> Canadian dollars, except per share data)<br />

3. SIGNIFICANT ACCOUNTING POLICIES (continued)<br />

(u) Associate Interest<br />

Associate interest reflects the investment the Associates have in the net assets <strong>of</strong> their businesses.<br />

Under the terms <strong>of</strong> the Company’s agreements with Associates (the “Associate Agreements”), the<br />

Company agrees to purchase the assets that the Associates use in store operations, primarily at the<br />

carrying value to the Associate, when Associate Agreements are terminated by either party.<br />

(v) New Standards and Interpretations not yet Adopted<br />

A number <strong>of</strong> new standards, amendments to standards and interpretations have been issued but are<br />

not yet effective for the financial year ending December 31, 2011, and accordingly, have not been<br />

applied in preparing these consolidated financial statements:<br />

(i) <strong>Financial</strong> Instruments – Disclosures<br />

The IASB has issued an amendment to IFRS 7, “<strong>Financial</strong> Instruments: Disclosures” (“IFRS 7<br />

amendment”), requiring incremental disclosures regarding transfers <strong>of</strong> financial assets. This<br />

amendment is effective for annual periods beginning on or after July 1, 2011. The Company will<br />

apply the amendment at the beginning <strong>of</strong> its 2012 financial year and does not expect the<br />

implementation to have a significant impact on the Company’s disclosures.<br />

(ii) Deferred Taxes – Recovery <strong>of</strong> Underlying Assets<br />

The IASB has issued an amendment to IAS 12, “Income Taxes” (“IAS 12 amendment”), which<br />

introduces an exception to the general measurement requirements <strong>of</strong> IAS 12 in respect <strong>of</strong> investment<br />

properties measured at fair value. The IAS 12 amendment is effective for annual periods beginning<br />

on or after January 1, 2012. The Company will apply the amendment at the beginning <strong>of</strong> its 2012<br />

financial year. The Company has yet to assess the impact <strong>of</strong> the IAS 12 amendment on its results <strong>of</strong><br />

operations, financial position and disclosures.<br />

(iii) <strong>Financial</strong> Instruments<br />

The IASB has issued a new standard, IFRS 9, “<strong>Financial</strong> Instruments” (“IFRS 9”), which will<br />

ultimately replace IAS 39, “<strong>Financial</strong> Instruments: Recognition and Measurement” (“IAS 39”). The<br />

replacement <strong>of</strong> IAS 39 is a multi-phase project with the objective <strong>of</strong> improving and simplifying the<br />

reporting for financial instruments and the issuance <strong>of</strong> IFRS 9 is part <strong>of</strong> the first phase. This standard<br />

becomes effective on January 1, 2013. The Company has yet to assess the impact <strong>of</strong> the new standard<br />

on its results <strong>of</strong> operations, financial position and disclosures.<br />

40

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!